Last reviewed · How we verify
NCT05455905
Voice Biomarkers Predictive of Depression and Anxiety
trial testing Patient Health Questionnaire-9 in Depression, Anxiety in 19,533 participants. Completed in 11 September 2022.
11 September 2022
Quick facts
| Lead sponsor | Kintsugi Mindful Wellness, Inc. |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 19,533 |
| Start date | 14 September 2021 |
| Primary completion | 11 September 2022 |
| Estimated completion | 11 September 2022 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Patient Health Questionnaire-9
- Generalized Anxiety Disorder-7
- Hamilton Depression Rating Scale
- Hamilton Anxiety Rating Scale
Conditions studied
- Depression, Anxiety — all drugs for Depression, Anxiety →
- Healthy — all drugs for Healthy →
- Mental Health Wellness 1 — all drugs for Mental Health Wellness 1 →
Sponsor
Kintsugi Mindful Wellness, Inc.
Who can join
18 and older, any sex, with Depression, Anxiety or Healthy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The objective of this study is to collect data to improve the sensitivity and specificity of Kintsugi Voice's (formerly KiVATM) predictions on audio files. A web-based audio recording tool will be used to record voice sample and ask participants the PHQ-9 and GAD-7 questions. A voluntary subset of participants will then be assessed by mental health professionals with the Hamilton Depression Rating Scale (HAM-D) and Hamilton Anxiety Rating Scale (HAM-A) scores.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT05455905
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Patient Health Questionnaire-9
Trials testing the same drug.
- NCT03503383 — Evaluation of Psychological Status in Pregnant Women Complaining of Hypertension With Pregnancy · unknown
Other recruiting trials for Depression, Anxiety
Currently open trials in the same condition.
- NCT07278466 — The COMParing App Support Strategies Study · NA · recruiting
- NCT07280481 — Weekly Dynamics of Psychopathological and Symptom Networks During Mindfulness-Based Interventions for Emotional Distress · NA · recruiting
- NCT07014852 — Integrating Inuit Knowledge Principles in Multi-Level Mental Health Clinical Trials · EARLY_PHASE1 · recruiting
- NCT07186816 — SUpport From PEeRs to Expand Access Study - Community · NA · recruiting
- NCT07091032 — Building Connections · NA · recruiting
Other Kintsugi Mindful Wellness, Inc. trials
Trials by the same sponsor.
- NCT06374056 — Kintsugi Voice Device Pilot Study · active not recruiting
- NCT05554042 — Kintsugi Voice Device Study · completed
- NCT04510519 — Scaling Mental Healthcare in COVID-19 With Voice Biomarkers · completed
- NCT04874077 — Using Voice Biomarkers to Predict the Likelihood of Major Depressive Disorder · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05455905 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Kintsugi Mindful Wellness, Inc.
- Last refreshed: 15 September 2022
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05455905.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing